首页> Lung cancer (Amsterdam, Netherlands)> A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.

A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.

导出 LinkOut

翻译打印收藏纠错

第一作者： Rosalyn A,Juergens

第一单位： Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada.

作者： Rosalyn A,Juergens ^[1] ; Desiree,Hao ^[2] ; Peter M,Ellis ^[1] ; Dongsheng,Tu ^[3] ; Mihaela,Mates ^[4] ; Christian,Kollmannsberger ^[5] ; Penelope A,Bradbury ^[6] ; Moustapha,Tehfe ^[7] ; Paul,Wheatley-Price ^[8] ; Andrew,Robinson ^[4] ; Gwyn,Bebb ^[2] ; Janessa,Laskin ^[5] ; John,Goffin ^[1] ; John,Hilton ^[8] ; Anna,Tomiak ^[4] ; Sebastien,Hotte ^[1] ; Glenwood D,Goss ^[8] ; Pamela,Brown-Walker ^[3] ; Xiaoqun,Sun ^[3] ; Ming-Sound,Tsao ^[6] ; Michael,Cabanero ^[6] ; Isabelle,Gauthier ^[3] ; Xuyang,Song ^[9] ; Phillip A,Dennis ^[9] ; Lesley K,Seymour ^[10] ; Martin,Smoragiewicz ^[3] ; Scott A,Laurie ^[8]

作者单位： Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada. ^[1] Tom Baker Cancer Center, Cummings School of Medicine, University of Calgary, Calgary, AB, Canada. ^[2] Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. ^[3] Cancer Center of Southeastern Ontario, Kingston, Ontario, Canada. ^[4] British Columbia Cancer Agency - Vancouver Cancer Center, Vancouver, British Columbia, Canada. ^[5] Princess Margaret Cancer Center, Toronto, Ontario, Canada. ^[6] CHUM Montreal, Quebec, Canada. ^[7] The Ottawa Hospital Cancer Centre, Division of Medical Oncology, Ottawa, ON, Canada. ^[8] Global Medicines Development, AstraZeneca, Gaithersburg, Maryland, USA. ^[9] Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada. Electronic address: lseymour@ctg.queensu.ca. ^[10]

关键词 Durvalumab Immunotherapy Lung cancer Phase I Tremelimumab